control group:PD-1 monoclonal antibody

2 trials

Sponsors

The Ninth People's Hospital Affiliated to Medical School of Shanghai Jiaotong University, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Conditions

head and neck mucosal melanomalung cancer

Phase 2

Prospective clinical trial of anticancer vascular inhibitors combined with PD-1 monoclonal antibody in the treatment of metastatic and / or unresectable head and neck mucosal melanoma

Active, not recruitingChiCTR2000036500

The Ninth People's Hospital Affiliated to Medical School of Shanghai Jiaotong Universityhead and neck mucosal melanoma

Start: 2020-10-01Updated: 2020-09-14

Unknown Phase

Clinical Study on the Impact of Qidongning Formula Combined with PD-1 Antibody on the Immune Function of Patients with Advanced Non-small Cell Lung Cancer

Active, not recruitingITMCTR2025001118

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicinelung cancer

Start: 2025-06-15Updated: 2025-06-24